# Clinical Effect and Safety of Tamsulosin 0.4mg in Patients With LUTS/BPH Refractory to Tamsulosin 0.2mg

> **NCT00954889** · NA · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 220 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **DRUG:** tamsulosin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00954889
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-08
- **Primary completion:** 2011-11
- **Final completion:** —
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2011-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00954889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00954889, "Clinical Effect and Safety of Tamsulosin 0.4mg in Patients With LUTS/BPH Refractory to Tamsulosin 0.2mg". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00954889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*